I am shocked and horrified by the guidelines just issued by the American Heart Association and American College of Cardiology which speak of giving statin drugs to well people. The “experts” who have issued the new directives claim that healthy people should take statin drugs as a “preventative against possible future illness.” They want to see one third of all adults in the United States on statin drugs—44% of all men and 22% of all women.
One in four Americans over 45 are already on statins, despite more than 900 studies reporting dangerous side effects from these drugs.
Reported side effects of statins range from heightened risks of cancer and diabetes to sexual problems, neuropathy and liver dysfunction, as well as immune system suppression—even a higher risk of cataracts.
In Britain, statins are the most commonly prescribed drugs already. Currently between 6 and 8 million people are taking them. If the new directives are accepted by the UK medical establishment—as they are likely to be—the numbers of men and women being prescribed statins could well become legion.
WHAT ARE STATINS?
Statins are a group of drugs prescribed to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. They have many different names such as Lipitor, Lescol, Mevacor, Altocor and Zocor, to mention only a few. These drugs are prescribed on the assumption that they lower the risks of cardiovascular events and strokes.
The new directives assert that, if given to healthy people, they could help protect the population from heart attacks and strokes at some time in the future.
Happily, a growing number of cardiologists are strongly opposed to the new directives. These cardiologists insist that the new directives should be suspended. Sadly, few media outlets have so far reported on the negative assertions to the new directives from physicians who oppose them. The U-T San Diego newspaper is a welcome exception. It reports, “Doctors assail new guidelines for statins.” Then it goes on to say that “Many physicians have since come out and said that the risk calculator [used in the new directives] was based on bad information, and that if it is used, millions of people who don’t need statins will be urged to take them.”
WELCOME NEWS
Last year, Dr Eric Topol, highly respected cardiologist and professor of genomics at Scripps Research Institute in California wrote an excellent article for the New York Times Opinion Page on February 29, 1912. In it he warns that “We’re overdosing on cholesterol-lowering statins.” Topol is especially concerned about the sharp increase in the prevalence of Type 2 Diabetes that is occurring in people using them. He writes, “Statins have been available since the 1980s but their risk of inducing diabetes did not surface for nearly 20 years. When all the data available from multiple studies was pooled in 2010 for more than 91,000 patients randomly assigned to be treated with a statin or a sugar pill (placebo), the risk of developing diabetes with any statin was one in every 255 patients treated. But this figure is misleading since it includes weaker statins like Pravachol and Mevacor—which were introduced earlier and do not carry any clear-cut risk. It is only with the more potent statins—Zocor (now known as simvastatin), Lipitor (atorvastatin) and Crestor (rosuvastatin)—particularly at higher doses, that the risk of diabetes shows up.
The cause and effect was unequivocal because the multiple large trials of the more potent statins had a consistent excess of diabetes.”
Meanwhile, a recent study in the Journal of Cancer Epidemiology, Biomarkers & Prevention by Jean A McDougall and her colleagues reveals that
long-term use of statins increases the risk of both lobular and ductal breast cancer in women between 55 and 74.
BOTTOM LINE
In the past four and a half years, I have worked with hundreds of men and women whose doctors had been prescribing statins as they began their Cura Romana Journey Program. I always insist that they let their health practitioner know what they are doing, so that he or she can monitor carefully the dosages they are prescribing while they are following the program. This is essential, since no physician wants to prescribe more of any drug than is absolutely necessary, and the need for statins and other medications tends to decrease dramatically on the Cura Romana experience. At the end of their CR program, participants regularly send us reports like this one:
“Before Cura Romana I had been taking 50mg of Levothyroxine per day as well as 40mgs of Simvastatin per day. I had chronic constipation, hemorrhoids, raised cholesterol etc. Now, not only am I free of the drugs, I no longer experience any of these conditions,” writes Debbie in the UK.
I am no doctor, but what I have learned during my more than forty years of writing and broadcasting on health is this: When a body is restored to healthy functioning naturally, the need for medication is either dramatically reduced or, more often than not, eliminated altogether.
Statins, like most pharmaceuticals, treat symptoms—they do not heal. Only nature can heal from within. My advice to anyone thinking of accepting the new directives is this: Before you agree to take statins, be sure to research well the implications of doing so. There are other natural ways of clearing cholesterol issues. Learn as much as you can about statin drugs as well as the natural alternatives. Here are just a few suggestions about where you can begin finding out more.
RESOURCES
U-T San Diego “Doctors assail new guidelines for statins: 18 November, 2013
Cancer Epidemiology, Biomarkers & Prevention; Published Online First July 5, 2013; doi: 10.1158/1055-9965.EPI-13-0414
This is an excellent compilation of dangers from statin drugs with links to abstracts.
Click Here
JAMA Ophthalmol 2013 Nov 1;131(11):1427-34. doi: 10.1001/jamaophthalmol.2013.4575.
Association of statin use with cataracts: a propensity score-matched analysis. This is a good source of information on the use of statins for the elderly.
Click Here
Sultan and N. Hynes, "The Ugly Side of Statins. Systemic Appraisal of the Contemporary Un-Known Unknowns," Open Journal of Endocrine and Metabolic Diseases, Vol. 3 No. 3, 2013, pp. 179-185. doi: 10.4236/ojemd.2013.33025.
I also recommend visiting
Mercola.com and typing in
“statins” since you will find some good information here too.
